Covered recipient · General Payments record
JENNIFER MOONEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$714.45
- Reported across 42 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $302.86 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $111.72 | 7 |
| Novo Nordisk AS | $35.10 | 2 |
| Amgen Inc. | $31.63 | 2 |
| Lilly USA, LLC | $28.54 | 2 |
| DEXCOM, INC. | $22.09 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.03 | 1 |
| Acerta Pharma LLC | $19.09 | 1 |
| GlaxoSmithKline, LLC. | $17.65 | 1 |
| Exact Sciences Corporation | $17.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.59 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228941003 | CMS |
| Amgen Inc. | $15.04 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228941010 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.09 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206258172 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.03 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222800557 | CMS |
| Dexcom, Inc. | $22.09 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250560172 | CMS |
| Exact Sciences Corporation | $17.01 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235290046 | CMS |
| GlaxoSmithKline, LLC. | $17.65 | 03/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191668420 | CMS |
| Lilly USA, LLC | $14.76 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187080943 | CMS |
| Lilly USA, LLC | $13.78 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187036329 | CMS |
| Novo Nordisk Inc | $18.75 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188522049 | CMS |
| Novo Nordisk Inc | $16.35 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188677747 | CMS |
| PFIZER INC. | $14.22 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230483630 | CMS |
| PFIZER INC. | $14.81 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230485174 | CMS |
| PFIZER INC. | $16.68 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230484509 | CMS |
| PFIZER INC. | $14.31 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230497617 | CMS |
| PFIZER INC. | $15.20 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230536892 | CMS |
| PFIZER INC. | $20.51 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230577381 | CMS |
| PFIZER INC. | $15.99 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230923556 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.